Advances in targeted therapy of cholangiocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in targeted therapy of cholangiocarcinoma

Published:2024-02-15 Issue:1 Volume:56 Page:
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Li Yuhang¹,Yu Jianfeng¹²,Zhang Yujing²,Peng Chuang¹³⁴,Song Yinghui²,Liu Sulai¹²³⁴^ORCID

Affiliation:

1. Department of Hepatobiliary Surgery, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan Province, China

2. Central Laboratory, Hunan Provincial People’s Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, Hunan Province, China

3. Hunan Provincial Key Laboratory of Biliary Disease Prevention and Treatment, Changsha, Hunan Province, China

4. Clinical Medical Technology Research Center of Hunan Provincial for Biliary Disease Prevention and Treatment, Changsha, Hunan Province, China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2024.2310196

Reference74 articles.

1. Cholangiocarcinoma

2. Classifications and misclassification in cholangiocarcinoma

3. Clinical treatment of cholangiocarcinoma: an updated comprehensive review

4. MicroRNA-129-2-3p directly targets Wip1 to suppress the proliferation and invasion of intrahepatic cholangiocarcinoma

5. Application of Laparoscopic Radical Resection for Type III and IV Hilar Cholangiocarcinoma Treatment

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biliary stents for active materials and surface modification: Recent advances and future perspectives;Bioactive Materials;2024-12

2. Strategies for treating the cold tumors of cholangiocarcinoma: core concepts and future directions;Clinical and Experimental Medicine;2024-08-14

3. Image-Guided Ablation for Cholangiocarcinoma: Current Evidence and Future Directions;Digestive Disease Interventions;2024-08-13

4. Editorial: Clinical management of cholangiocarcinoma: surgical approaches and therapies;Frontiers in Oncology;2024-07-29

5. Strategies to enhance the response of liver cancer to pharmacological treatments;American Journal of Physiology-Cell Physiology;2024-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3